Comparison of two different types of injection in the treatment of periarthritis of shoulder.

Not Applicable

Conditions: Health Condition 1: M249- Joint derangement, unspecified

Registration Number: CTRI/2021/09/036322

Lead Sponsor: Department of Anaesthesiology and Critical Care JNMCHAMU Aligarh

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1. Age >18 years

2. ASA Grade I and II patients

3. Patients of persistent shoulder pain diagnosed clinically and radiologically

4. More than 1/3rd restriction of shoulder flexion, abduction and external rotation

5. Willingness to participate in the study and forgo any other concomitant treatment modality

Exclusion Criteria

1. Unwillingness to participate in the study

2. Intrinsic glenohumeral pathology

3. History of shoulder trauma or surgery

4. History of injection in the involved shoulder during preceding 6 months

5. Patients with haematological disorders or on antiplatelet or anticoagulant therapy, or hypersensitivity to local anaesthetics, or receiving anticoagulants, aspirin, aspirin containing NSAIDS.

6. Pregnant and breastfeeding females

7. Uncontrolled psychiatric disorder or major depression or other severe medical illness

8. Local infection or ongoing septicaemia

9. Patients with autoimmune disease, malignancy, uncontrolled diabetes mellitus, hyperlipidemia and patients with BMI >30

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To determine the degree and duration of pain relief in patients of periarthritis of shoulder using Numerical Rating Scale (NRS)Timepoint: Baseline, 1st week, 3rd week and 6th week

Secondary Outcome Measures

Name	Time	Method
1. To evaluate the improvement in shoulder function of patient using Shoulder pain and Disability Index (SPADI) <br/ ><br>2. Requirement of rescue analgesics on weekly basis <br/ ><br>3. Complications such as pain, bleeding, infection or any other complication occurring during and after injection shall be notedTimepoint: Improvement in shoulder function was assessed in the form of SPADI at 1st, 3rd and 6th week taking the shoulder function at the day of intervention as baseline <br/ ><br>The analgesics taken by the patient were recorded on weekly basis <br/ ><br>Any complication occurring was taken into account at 1st, 3rd and 6th week